Sale

Neutropenia Treatment Market

Global Neutropenia Treatment Market Size, Trends, Analysis: By Treatment: Colony-stimulating factors, Antibiotics, Antifungals, Antivirals; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; 2024-2032

Global Neutropenia Treatment Market Outlook

The global neutropenia treatment market reached a value of about USD 15.69 billion in 2023. The market is projected to grow at a CAGR of 5.3% during the forecast period of 2024-2032 to attain a value of nearly USD 25.09 billion by 2032.  

 

Global Neutropenia Treatment Marke

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Awareness of Neutropenia and Side-effects of Chemotherapy to Augment the Market Growth

In the forecast period, rising awareness of neutropenia and chemotherapy-related side effects, as well as increasing diagnostic technologies, are expected to help accelerate the rise of neutropenia treatment. The significant increase is attributed to a promising therapeutic pipeline that includes around 5 medicines in phase III clinical studies to treat neutropenia. The risk of neutropenia is predicted to increase as the prevalence of leukaemia rises, particularly after treatment.

One of the major drivers of market expansion is new therapies paired with an increase in occurrences of chemotherapy-induced neutropenia. Furthermore, the innovative medication delivery technique improves patient comfort, resulting in increased patient adherence and, as a result, market growth. Furthermore, because cancer is a known cause of neutropenia, the market for neutropenia treatment will benefit from an increase in the number of instances of chemotherapy for cancer treatment.

 

North America Accounted for the Largest Share While the Asia Pacific is the Fastest Growing Region in the Market

In the worldwide neutropenia treatment industry, North America held the biggest share. North America has had tremendous expansion in the neutropenia treatment industry, and it is likely to dominate the market in the future years. This is due to an increase in the number of cases of leukaemia in the area. In addition, North America is home to many of the market's main participants. Furthermore, the United States dominates the need for neutropenia therapy in North America. The region's dominance is attributable to an increase in demand for febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars. Throughout the forecast period, the Asia Pacific is predicted to develop at the fastest rate in the market. Due to the increasing number of leukaemia cases and patients undergoing first-line chemotherapy treatment in Asia, the neutropenia treatment industry has a lot of room to grow.

 

Neutropenia Treatment: Market Segmentation

Neutropenia is a rare disease characterised by a sharp drop in neutrophil counts, resulting in weakened immunity. Neutropenia can be caused by a variety of diseases or situations, including chemotherapy for cancer, infections, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia).

 

Global Neutropenia Treatment Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of treatment, neutropenia treatment industry is segmented into:

  • Colony-stimulating factors 
  • Antibiotics
  • Antifungals
  • Antivirals

Based on the distribution channel, the market is divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The major regional markets of neutropenia treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Neutropenia Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Focus on Research and Development Activities by Companies to Bolster the Market Growth

The neutropenia treatment industry is expected to increase considerably due to major players in the industry supporting research and development as well as public awareness of neutropenia therapy. Companies in this market are focusing on raising knowledge about preventive measures, early diagnosis, and effective treatment of neutropenia as major market tactics. The introduction of small molecules is one of the major technologies gaining traction in the worldwide neutropenia treatment industry. The development of Plinabulin, a tiny chemical with immune-boosting properties created by BeyondSpring Pharmaceuticals, is expected to transform neutropenia treatment. In addition to its immune-boosting properties, Phase II tests have shown that this chemical has even more effective anti-cancer properties. In the neutropenia treatment industry, there is now a significant need for cost-effective medicines. As a result, suppliers are concentrating their efforts on the development of small molecules that have lower processing costs than biologics.

 

Key Industry Players in the Global Neutropenia Treatment Market

The report gives a detailed analysis of the following key players in the global neutropenia treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Amgen, INC.
  • Beyondspring, INC.
  • Cellerant Therapeutics, Inc.
  • Kyowa Kirin 
  • Pfizer INC. 
  • Novartis Ag 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment
  • Distribution Channel
  • Region
Breakup by Treatment
  • Colony-stimulating factors 
  • Antibiotics
  • Antifungals
  • Antivirals
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies 
  • Online Pharmacies
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Amgen, INC.
  • Beyondspring, INC.
  • Cellerant Therapeutics, Inc.
  • Kyowa Kirin
  • Pfizer INC.
  • Novartis Ag
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Neutropenia Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Neutropenia Treatment Historical Market (2018-2023) 
    8.3    Global Neutropenia Treatment Market Forecast (2024-2032)
    8.4    Global Neutropenia Treatment Market by Treatment
        8.4.1    Colony-stimulating factors 
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Antibiotics
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Antifungals
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Antivirals
            8.4.4.1    Historical Trend (2018-2023)
            8.4.4.2    Forecast Trend (2024-2032)
    8.5    Global Neutropenia Treatment Market by Distribution Channel
        8.5.1    Hospital Pharmacies  
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Retail Pharmacies 
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Online Pharmacies 
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)    
    8.6    Global Neutropenia Treatment Market by Region
        8.6.1    North America
            8.6.1.1    Historical Trend (2018-2023) 
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Europe
            8.6.2.1    Historical Trend (2018-2023) 
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Asia Pacific
            8.6.3.1    Historical Trend (2018-2023) 
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Latin America
            8.6.4.1    Historical Trend (2018-2023) 
            8.6.4.2    Forecast Trend (2024-2032)
        8.6.5    Middle East and Africa
            8.6.5.1    Historical Trend (2018-2023) 
            8.6.5.2    Forecast Trend (2024-2032) 
9    North America Neutropenia Treatment Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Neutropenia Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Neutropenia Treatment Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.2    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Neutropenia Treatment Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Neutropenia Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Amgen, INC.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Beyondspring, INC.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Cellerant Therapeutics, Inc.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Kyowa Kirin
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Pfizer INC.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Novartis Ag
            16.2.6.1    Company Overview
            16.2.6.2    Product Portfolio
            16.2.6.3    Demographic Reach and Achievements
            16.2.6.4    Certifications
        16.2.7    Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Neutropenia Treatment Market: Key Industry Highlights, 2018 and 2032
2.    Global Neutropenia Treatment Historical Market: Breakup by Treatment (USD Billion), 2018-2023
3.    Global Neutropenia Treatment Market Forecast: Breakup by Treatment (USD Billion), 2024-2032
4.    Global Neutropenia Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
5.    Global Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
6.    Global Neutropenia Treatment Historical Market: Breakup by Region (USD Billion), 2018-2023
7.    Global Neutropenia Treatment Market Forecast: Breakup by Region (USD Billion), 2024-2032
8.    North America Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
9.    North America Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
10.    Europe Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
11.    Europe Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
12.    Asia Pacific Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
13.    Asia Pacific Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.    Latin America Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    Latin America Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Middle East and Africa Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
17.    Middle East and Africa Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.    Global Neutropenia Treatment Market Structure

Key Questions Answered in the Report

In 2023, the global neutropenia treatment market attained a value of nearly USD 15.69 billion.

The market is projected to grow at a CAGR of 5.3% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 25.09 billion by 2032.  

The major drivers of the industry, such as rise in cancer cases leading to development of novel therapies and increasing number of R&D and investments by major players are expected to aid the market growth.

The key market trends guiding the growth of the industry include rising awareness of neutropenia and chemotherapy-related side effects, as well as increasing diagnostic technologies.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America dominating the market share in regional markets.

Colony stimulating factors segment is expected to be the dominant treatment in the industry due to the presence of major players who are focused on the development of colony-stimulating factor based drugs.

The distribution channel segment is led by hospital pharmacies segment of the market.

The major players in the industry are Amgen, INC., Beyondspring, INC., Cellerant Therapeutics, Inc., Kyowa Kirin, Pfizer INC., and Novartis Ag, among others.

Analyst Review

The global neutropenia treatment market attained a value of about USD 15.69 billion in 2023, driven by the rise in cancer cases leading to development of novel therapies. Aided by the rising awareness of neutropenia and chemotherapy-related side effects, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 5.3%. The market is projected to reach nearly USD 25.09 billion by 2032.  

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on treatment, the neutropenia treatment industry can be segmented into colony-stimulating factors, antibiotics, antifungals, and antivirals. On the basis of distribution channel, the industry is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for neutropenia treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America dominating the market share. The key players in the above market include Amgen, INC., Beyondspring, INC., Cellerant Therapeutics, Inc., Kyowa Kirin, Pfizer INC., and Novartis Ag, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER